Abstract
Background: There, we review the pathogenesis of gestational diabetes mellitus (GDM), its influence on fetal physiology, and neonatal outcomes, as well as the usage of antenatal corticosteroid therapy (ACST) in pregnancies complicated by GDM. Methods: MEDLINE and PubMed search was performed for the years 1990–2022, using a combination of keywords on such topics. According to the aim of the investigation, appropriate articles were identified and included in this narrative review. Results: GDM is a multifactorial disease related to unwanted pregnancy course and outcomes. Although GDM has an influence on the fetal cardiovascular and nervous system, especially in preterm neonates, the usage of ACST in pregnancy must be considered taking into account maternal and fetal characteristics. Conclusions: GDM has no influence on neonatal outcomes after ACST introduction. The ACST usage must be personalized and considered according to its gestational age-specific effects on the developing fetus.
Reference81 articles.
1. American Diabetes Association (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care, 32, S62–S67.
2. Lawrence, R.L., Wall, C.R., and Bloomfield, F.H. (2019). Prevalence of gestational diabetes according to commonly used data sources: An observational study. BMC Pregnancy Childbirth, 19.
3. Perinatal outcome in pregnancies complicated with gestational diabetes mellitus and very preterm birth: Case–control study;Deryabina;Gynecol. Endocrinol.,2016
4. Impact of Maternal Gestational Diabetes on Neonatal Outcome of Late Preterm Infants;Fung;Clin. Pediatr.,2020
5. FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine (2019). Good clinical practice advice: Antenatal corticosteroids for fetal lung maturation. Int. J. Gynaecol. Obstet., 144, 352–355.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献